Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tapentadol hydrochloride |
Is a |
False |
Tapentadol |
Inferred relationship |
Some |
|
Product containing tapentadol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tapentadol |
Inferred relationship |
Some |
|
Tapentadol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing only tapentadol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 4 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol (as tapentadol hydrochloride) 20 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tapentadol |
Inferred relationship |
Some |
1 |
Tapentadol maleate hemihydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tapentadol |
Inferred relationship |
Some |
|